Tirofiban is a:
**Core Concept**
Tirofiban is an antiplatelet medication that selectively and reversibly blocks the glycoprotein IIb/IIIa receptor on platelets. This action prevents platelet aggregation by inhibiting the binding of fibrinogen to the glycoprotein IIb/IIIa receptor.
**Why the Correct Answer is Right**
Tirofiban works by binding to the glycoprotein IIb/IIIa receptor, which is a key component of the platelet aggregation pathway. By blocking this receptor, tirofiban prevents platelets from aggregating and forming blood clots. This mechanism is particularly useful in patients with acute coronary syndromes, where platelet aggregation plays a critical role in the development of thrombi.
**Why Each Wrong Option is Incorrect**
**Option A:** is incorrect because it does not accurately describe the mechanism of action of tirofiban.
**Option B:** is incorrect because it is a different class of antiplatelet medication that works through a different mechanism.
**Option C:** is incorrect because it is a type of anticoagulant that works through a different mechanism.
**Clinical Pearl / High-Yield Fact**
Tirofiban is a useful medication in the management of acute coronary syndromes, particularly in patients who are at high risk of thrombotic complications. It is often used in conjunction with other antiplatelet medications, such as aspirin and clopidogrel, to achieve optimal antiplatelet therapy.
**Correct Answer:** C.